Drug interactions for the following drug(s)
Applies to: Methyldopa 125 MG Oral Tablet <> Cefadroxil 500 MG Oral Capsule
Cefadroxil may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Applies to: Methyldopa 125 MG Oral Tablet <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
Ferrous sulfate anhydrous can cause a decrease in the absorption of Methyldopa resulting in a reduced serum concentration and potentially a decrease in efficacy.
Applies to: Cefadroxil 500 MG Oral Capsule <> Mefenamic Acid 250 MG Oral Capsule
Mefenamic acid may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Applies to: NIFEdipine 30 MG 24HR Extended Release Oral Tablet <> Mefenamic Acid 250 MG Oral Capsule
Mefenamic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Applies to: Methyldopa 125 MG Oral Tablet <> Mefenamic Acid 250 MG Oral Capsule
The therapeutic efficacy of Methyldopa can be decreased when used in combination with Mefenamic acid.
Applies to: NIFEdipine 30 MG 24HR Extended Release Oral Tablet <> Cefadroxil 500 MG Oral Capsule
Cefadroxil may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Applies to: Methyldopa 125 MG Oral Tablet <> NIFEdipine 30 MG 24HR Extended Release Oral Tablet
Nifedipine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Methyldopa 125 MG Oral Tablet <> Cefadroxil 500 MG Oral Capsule
Drug1 (rxcui = 197955, name = methyldopa 125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309049, name = cefadroxil 500 MG Oral Capsule, tty = SCD). Drug1 is resolved to methyldopa, Drug2 is resolved to cefadroxil anhydrous and interaction asserted in DrugBank between Methyldopa and Cefadroxil. Drug1 is resolved to cefadroxil, Drug2 is resolved to methyldopa anhydrous and interaction asserted in DrugBank between Cefadroxil and Methyldopa. Drug1 is resolved to cefadroxil anhydrous, Drug2 is resolved to methyldopa anhydrous and interaction asserted in DrugBank between Cefadroxil and Methyldopa. Drug1 is resolved to cefadroxil, Drug2 is resolved to methyldopa and interaction asserted in DrugBank between Cefadroxil and Methyldopa.
Applies to: Methyldopa 125 MG Oral Tablet <> ferrous sulfate 324 MG (iron 65 MG) Oral Tablet
Drug1 (rxcui = 197955, name = methyldopa 125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310325, name = ferrous sulfate 325 MG Oral Tablet, tty = SCD). Drug1 is resolved to methyldopa, Drug2 is resolved to ferrous sulfate and interaction asserted in DrugBank between Methyldopa and Ferrous sulfate anhydrous. Drug1 is resolved to ferrous sulfate, Drug2 is resolved to methyldopa anhydrous and interaction asserted in DrugBank between Ferrous sulfate anhydrous and Methyldopa.
Applies to: Cefadroxil 500 MG Oral Capsule <> Mefenamic Acid 250 MG Oral Capsule
Drug1 (rxcui = 309049, name = cefadroxil 500 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 829500, name = mefenamic acid 250 MG Oral Capsule, tty = SCD). Drug1 is resolved to cefadroxil, Drug2 is resolved to mefenamic acid and interaction asserted in DrugBank between Cefadroxil and Mefenamic acid. Drug1 is resolved to mefenamic acid, Drug2 is resolved to cefadroxil anhydrous and interaction asserted in DrugBank between Mefenamic acid and Cefadroxil.
Applies to: NIFEdipine 30 MG 24HR Extended Release Oral Tablet <> Mefenamic Acid 250 MG Oral Capsule
Drug1 (rxcui = 198034, name = 24 HR nifedipine 30 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 829500, name = mefenamic acid 250 MG Oral Capsule, tty = SCD). Drug1 is resolved to mefenamic acid, Drug2 is resolved to nifedipine and interaction asserted in DrugBank between Mefenamic acid and Nifedipine.
Applies to: Methyldopa 125 MG Oral Tablet <> Mefenamic Acid 250 MG Oral Capsule
Drug1 (rxcui = 197955, name = methyldopa 125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 829500, name = mefenamic acid 250 MG Oral Capsule, tty = SCD). Drug1 is resolved to mefenamic acid, Drug2 is resolved to methyldopa anhydrous and interaction asserted in DrugBank between Mefenamic acid and Methyldopa. Drug1 is resolved to mefenamic acid, Drug2 is resolved to methyldopa and interaction asserted in DrugBank between Mefenamic acid and Methyldopa.
Applies to: NIFEdipine 30 MG 24HR Extended Release Oral Tablet <> Cefadroxil 500 MG Oral Capsule
Drug1 (rxcui = 198034, name = 24 HR nifedipine 30 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 309049, name = cefadroxil 500 MG Oral Capsule, tty = SCD). Drug1 is resolved to nifedipine, Drug2 is resolved to cefadroxil anhydrous and interaction asserted in DrugBank between Nifedipine and Cefadroxil. Drug1 is resolved to cefadroxil, Drug2 is resolved to nifedipine and interaction asserted in DrugBank between Cefadroxil and Nifedipine.
Applies to: Methyldopa 125 MG Oral Tablet <> NIFEdipine 30 MG 24HR Extended Release Oral Tablet
Drug1 (rxcui = 197955, name = methyldopa 125 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 198034, name = 24 HR nifedipine 30 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to methyldopa, Drug2 is resolved to nifedipine and interaction asserted in DrugBank between Methyldopa and Nifedipine. Drug1 is resolved to nifedipine, Drug2 is resolved to methyldopa anhydrous and interaction asserted in DrugBank between Nifedipine and Methyldopa.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.